We use cookies and other technologies on this website to enhance your user experience.
By clicking any link on this page you are giving your consent to our Privacy Policy and Cookies Policy.

Over Rheumatology Advisor

Rheumatology knowledge for healthcare professionals to assist decision making.

The Rheumatology Advisor is a free, simple to use, medical app designed to be the essential resource for rheumatology specialists and healthcare providers to assist in making the right decisions for their patients. It provides daily healthcare news, the latest clinical cases, treatment review articles, opinions in medicine, CE/CME courses, and concise drug monographs.

The Rheumatology Advisor app aggregates the best rheumatology information from several partners including free CME/CE courses from myCME.com and drug information from eMPR.com, plus all of the content from our website.

Key Features include:

• Latest rheumatology news

• Full-length feature articles

• Concise drug monographs

• Unique rheumatology case studies

• Conference coverage

• Continuing Medical Education (CME) activities

• and more...

Our mission is to empower rheumatology healthcare professionals with practice-focused and comprehensive clinical and drug information that is reflective of current and emerging principles of care to help clinicians optimize patient outcomes.

Wat is er nieuw in de nieuwste versie 2.3.0.247

Last updated on Apr 12, 2018

Minor bug fixes and improvements

Vertaling Laden...

Aanvullende APP -informatie

Laatste Versie

Verzoek update van Rheumatology Advisor 2.3.0.247

Geüpload door

Alan Xavier

Android vereist

Android 4.4+

Meer Info

Rheumatology Advisor Screenshots

Talen
Abonneer u op APKPure
Wees de eerste die toegang krijgt tot de vroege release, nieuws en gidsen van de beste Android -games en apps.
Nee bedankt
Aanmelden
Succesvol ingeschreven!
Je bent nu geabonneerd op APKPure.
Abonneer u op APKPure
Wees de eerste die toegang krijgt tot de vroege release, nieuws en gidsen van de beste Android -games en apps.
Nee bedankt
Aanmelden
Succes!
Je bent nu geabonneerd op onze nieuwsbrief.